JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259173

Human TAF12 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TAF12 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

View Alternative Names

TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa, TAF12_HUMAN, TAF2J, TAFII-20/TAFII-15, TAFII20, Transcription initiation factor TFIID 20/15 kDa subunits, Transcription initiation factor TFIID subunit 12

1 Images
Sanger Sequencing - Human TAF12 knockout HeLa cell lysate (AB259173)
  • Sanger seq

Unknown

Sanger Sequencing - Human TAF12 knockout HeLa cell lysate (AB259173)

Homozygous : 1 bp insertion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259173-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TAF12 knockout HeLa cell lysate", "number":"AB259173-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259173-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TAF12
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TAF12 also known as Transcription initiation factor TFIID subunit 12 is a critical component of the transcription machinery specifically within the TFIID complex. This protein weighs approximately 22 kilodalton and acts as a bridge connecting different proteins within the transcriptional complex. TAF12 shows expression in various tissues with higher levels observed in actively dividing cells like those in the immune system or during embryonic development. Its expression pattern suggests a role in processes that require rapid gene expression changes.
Biological function summary

TAF12 contributes to the formation and stability of the TFIID complex which is essential for the initiation of transcription by RNA polymerase II. As part of this complex TAF12 helps recognize and bind to the core promoter elements of genes facilitating the assembly of the pre-initiation complex. This process drives gene expression that is responsive to various physiological signals. TAF12's interaction with other TAF (TBP-associated factors) proteins ensures precision in the selection of transcription start sites.

Pathways

TAF12 integrates into gene expression pathways affecting cellular proliferation and differentiation. Its role in the canonical Wnt signaling pathway is significant a pathway that regulates important aspects of development and cell signaling. TAF12 also interacts with proteins such as TAF1 and TBP which jointly influence transcription initiation. These protein interactions are fundamental for the regulation of genes that control cell cycle progression and response to external growth signals.

TAF12's function relates closely to cancer and neurodegenerative diseases. Its overexpression or misregulation may lead to oncogenesis as aberrant transcription can drive uncontrolled cell proliferation. In cancers TAF12's interaction with other transcription factors like the ETS family might contribute to tumorigenesis. Additionally alterations in TAF12 might be implicated in neurodegenerative disorders like Alzheimer's disease where the regulation of neuronal gene expression is disrupted. Studies are ongoing to understand fully how TAF12 and its associated proteins influence disease pathology and progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com